There is a medicinal spice so timelessly interwoven with the origins of human culture and metabolism, so thoroughly supported by modern scientific inquiry, as to be unparalleled in its proven value to human health and well-being.
Indeed, turmeric turns the entire drug-based medical model on its head. Rather than causing much more side effects than therapeutic ones, as is the case for most conventional pharmaceutical medications, turmeric possesses hundreds of thinkable benefits, having been tentatively demonstrated to positively modify over 160 different physiological pathways in the mammalian body.
While no food or herb is right for everyone, and everything has the potential for unintended, adverse side effects, turmeric is truly unique in its exceptionally high margin of safety vis-à-vis the drugs it has been compared with, e.g. hydrocortisone, ibuprofen, chemotherapy agents. Furthermore, nothing within the modern-day pharmaceutical armamentarium comes even remotely close to turmeric’s 6,000 year track record of safe use in Ayurvedic medicine.
In spite of its vast potential for relieving human suffering, turmeric will likely never get the FDA stamp of approval, due to its lack of individuality, patentability and therefore profitability.
Some of the most amazing demonstrated properties include:
- Destroying Multi-Drug Resistant Cancer
- Destroying Cancer Stem Cells (arguably, the root of all cancers)
- Protecting Against Radiation-Induced Damage
- Reducing Unhealthy Levels of Inflammation
- Protecting Against Heavy Metal Toxicity
- Preventing and Reversing Alzheimer’s Disease Associated Pathologies
What is so wonderful is not that turmeric may improve dozens of health conditions simultaneously, or that it may treat conditions that are completely resistant to conventional treatment, but that there are over six hundred additional health conditions it may also be valuable in preventing and/or treating. Consider the fact that turmeric grows liberally on the Earth, and you will understand why its very presence among us threatens billions of dollars in pharmaceutical industry income.